Hence, and as presented in the above results showing elevated OPN in liver fibrosis, we next sought to use neutralizing antibodies against OPN and associate trNKT phenotypic alteration of VDR and activity markers of CD107a and NKp46. The gene discussed is NCR1; the disease is Hepatic fibrosis.